Send to

Choose Destination
Cancer Cell. 2011 Feb 15;19(2):165-7. doi: 10.1016/j.ccr.2011.01.047.

PARP inhibitors in cancer therapy: promise, progress, and puzzles.

Author information

Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, 02114, USA.


A recent article in the New England Journal of Medicine by O'Shaughnessy et al. provides evidence that a treatment strategy aimed at inducing DNA damage with chemotherapy while simultaneously disabling repair using a PARP inhibitor might offer hope for patients with a treatment-refractory form of breast cancer.

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center